After Building New Plant and Signing on with AbbVie, Regenxbio Enters Commercial Phase
07/15/2022
An article in FiercePharma details the expansion plans of Regenxbio—with its new building as tangible evidence of its arrival as a burgeoning commercial business. Regenxbio recently opened a $65 million top-floor manufacturing facility, which was largely made possible by a transformational deal with AbbVie.